Oncolytic Viruses in the Treatment of Cancer: A Review of Current Strategies-Reference-Cited by-同舟云学术

Oncolytic Viruses in the Treatment of Cancer: A Review of Current Strategies

Published:2012-06-20 Issue:4 Volume:18 Page:771-781
ISSN:1219-4956
Container-title:Pathology & Oncology Research
language:en
Short-container-title:Pathol. Oncol. Res.

Author:

Zeyaullah Md.,Patro Mohan,Ahmad Irfan,Ibraheem Kawthar,Sultan P.,Nehal M.,Ali Arif

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,General Medicine,Pathology and Forensic Medicine

Link

http://link.springer.com/content/pdf/10.1007/s12253-012-9548-2.pdf

Reference143 articles.

1. Biederer C, Ries S, Brandts CH et al (2002) Replication-selective viruses for cancer therapy. J Mol Med 80:163–175

2. Chiocca AE (2002) Oncolytic viruses. Nat Rev Cancer 2:938–950

3. Everts B, Van der Poel HG (2005) Replication-selective oncolytic viruses in the treatment of cancer. Cancer Gene Ther 12(2):141–161

4. Guo ZS, Naik A, O’Malley ME et al (2005) The enhanced tumor selectivity of an oncolytic vaccinia lacking the host range and antiapoptosis genes SPI-1 and SPI-2. Cancer Res 65:9991–9998

5. Guo ZS, Thorne SH, Bartlett DL (2008) Oncolytic virotherapy: molecular targets in tumor-selective replication and carrier cell-mediated delivery of oncolytic viruses. Biochim Biophys Acta 1785:217–231

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in antitumour therapy with oncolytic herpes simplex virus combinations;Discover Oncology;2024-07-24

2. Bistability and chaotic behaviors in a 4D cancer oncolytic Virotherapy mathematical model: Pspice and FPGA implementations;Physica Scripta;2024-02-14

3. Utility of interventional endoscopic ultrasound in pancreatic cancer;Frontiers in Oncology;2023-09-15

4. Comprehensive assessment on the applications of oncolytic viruses for cancer immunotherapy;Frontiers in Pharmacology;2022-12-08

5. Repurposing live attenuated trivalent MMR vaccine as cost-effective cancer immunotherapy;Frontiers in Oncology;2022-11-09